What happened: Researchers have developed a simple DNA blood test that can forecast how well breast cancer patients will respond to specific treatments. This could help doctors offer the most effective therapy from the start.
Why it matters:
- Improves chances of successful treatment by personalising therapy choices.
- Benefits millions of breast cancer patients worldwide by reducing trial and error in treatment.
MNN Take: This test analyses DNA markers in the blood to guide treatment decisions, potentially speeding up recovery and reducing side effects by matching patients with the most suitable therapies.
Sources: Guardian UK